Conventional vs. atypical antipsychotic medications.

Conventional vs. atypical antipsychotic medications.

Bibliografische gegevens
Hoofdauteurs:	Barbui, C, Cipriani, A, Tansella, M
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2006

Gelijkaardige items

Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach.
door: Veronese, A, et al.
Gepubliceerd in: (2008)

Are atypical antipsychotic medications better than the conventional ones?
door: Pedro Miguel Milián Vázquez., et al.
Gepubliceerd in: (2005-04-01)

Are atypical antipsychotic medications better than the conventional ones?
door: Pedro Miguel Milián Vázquez., et al.
Gepubliceerd in: (2005-04-01)

Comparing the Effect of Atypical and Conventional Antipsychotics on Lipid Profile
door: Hamidreza Roohafza, et al.
Gepubliceerd in: (2015-03-01)

Comparison of systematic and narrative reviews: the example of the atypical antipsychotics.
door: Cipriani, A, et al.
Gepubliceerd in: (2003)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
door: Hülya Ertekin, et al.
Gepubliceerd in: (2016-08-01)

Atypical antipsychotics:
door: Claudia Aparecida Avelar Ferreira, et al.
Gepubliceerd in: (2015-10-01)

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
door: Cipriani, A, et al.
Gepubliceerd in: (2009)

Clinical Assessment of Weight Gain with Atypical Antipsychotics - Blonanserin vs Amisulpride
door: TS DEEPAK, et al.
Gepubliceerd in: (2015-06-01)

Asenapine: an atypical antipsychotic with atypical formulations
door: Meghan Musselman, et al.
Gepubliceerd in: (2021-09-01)

Atypical antipsychotics, more than just an antipsychotic
door: Hiram Tendilla-Beltran, et al.
Gepubliceerd in: (2020-01-01)

Attitudes to atypical and conventional antipsychotic drug treatment in clinicians participating in the cutlass study.
door: Lloyd, H, et al.
Gepubliceerd in: (2005)

Diabetes and atypical antipsychotics
door: Stathaki Maria, et al.
Gepubliceerd in: (2008-04-01)

Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review.
door: Mazzucco, S, et al.
Gepubliceerd in: (2008)

Validity of the impact factor of journals as a measure of randomized controlled trial quality.
door: Barbui, C, et al.
Gepubliceerd in: (2006)

Associated mortality risk of atypical antipsychotic medication in individuals with dementia
door: Phiri, P, et al.
Gepubliceerd in: (2022)

Oral discomfort and health behavior of patients with typical vs. atypical antipsychotic drugs
door: Jukka H. Meurman, et al.
Gepubliceerd in: (2024-06-01)

Gender differences in the use of atypical antipsychotic medications for ICU delirium
door: Kunal Karamchandani, et al.
Gepubliceerd in: (2018-09-01)

Does the addition of a second antipsychotic drug improve clozapine treatment?
door: Barbui, C, et al.
Gepubliceerd in: (2009)

Stimulant and atypical antipsychotic medications for children placed in foster homes.
door: L Oriana Linares, et al.
Gepubliceerd in: (2013-01-01)

Atypical antipsychotics (multiple letters)
door: McKenna, P, et al.
Gepubliceerd in: (2002)

Atypical antipsychotics in the treatment of schizophrenia
door: Swiss Medical Weekly
Gepubliceerd in: (2003-02-01)

Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies.
door: Barbui, C, et al.
Gepubliceerd in: (2014)

Anti-stress Properties of Atypical Antipsychotics
door: Alice Sanson, et al.
Gepubliceerd in: (2020-10-01)

[Atypical antipsychotic-induced weight gain].
door: Godlewska, B, et al.
Gepubliceerd in: (2006)

Atypical antipsychotic-induced weight gain
door: Godlewska, B, et al.
Gepubliceerd in: (2006)

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy
door: Nadkarni A, et al.
Gepubliceerd in: (2013-01-01)

Can atypical antipsychotic drugs cause hepatotoxicity?
door: R. André, et al.
Gepubliceerd in: (2021-04-01)

Seven criteria for improving effectiveness trials in psychiatry.
door: Tansella, M, et al.
Gepubliceerd in: (2006)

Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy.
door: Andretta, M, et al.
Gepubliceerd in: (2005)

Constrictive Pericarditis Associated with Atypical Antipsychotics
door: Kuan-chin Jean Chen, et al.
Gepubliceerd in: (2012-01-01)

Atypical Antipsychotics Induced Metabolic Syndrome
door: Aysegul Demirel, et al.
Gepubliceerd in: (2015-03-01)

Methamphetamine psychosis, the efficacy of atypical antipsychotics
door: Amir Rezaei Ardani, et al.
Gepubliceerd in: (2015-01-01)

Methamphetamine psychosis, the efficacy of atypical antipsychotics
door: Amir Rezaei Ardani, et al.
Gepubliceerd in: (2014-12-01)

New atypical antipsychotics for schizophrenia: iloperidone
door: Silvio Caccia, et al.
Gepubliceerd in: (2010-02-01)

Atypical antipsychotics for delirium in hospitalized patients
door: Daniza Belén Bilicic Ubierna, et al.
Gepubliceerd in: (2021-05-01)

Predictors of effect of atypical antipsychotics on speech
door: Preeti Sinha, et al.
Gepubliceerd in: (2015-01-01)

ATYPICAL ANTIPSYCHOTICS USE IN CHILDREN AND ADOLESCENTS
door: Nataša Potočnik-Dajčman, et al.
Gepubliceerd in: (2002-06-01)

Atypical antipsychotics in the treatment of schizophrenia - Reply
door: Geddes, J, et al.
Gepubliceerd in: (2001)

Cost-effectiveness of an atypical conventional antipsychotic in South Africa: An economic evaluation of quetiapine versus haloperidol in the treatment of patients partially responsive to previous antipsychotics
door: Robin Emsley, et al.
Gepubliceerd in: (2004-10-01)